Jason Henrichs has significant investing and operating experience in early stage companies. His experience includes serving as a Managing Direct at Rock Maple Ventures, a $80MM early stage technology fund, the Chief Operating Officer of U.S. Genomics, a Boston based developer of information technologies for the biotech industry and a Director of ctr!Ventures, a conception stage venture capital firm.

Previously, Mr. Henrichs was a strategy consultant at Monitor Company, where he specialized in strategy design and industry restructuring through acquisition and alliance. Prior to joining Monitor, Mr. Henrichs was a project engineer for Deluxe Corporation.

He is a director of Blacksmith Applications, Decision Biomarkers, MedVantx, Memento, Morphotek, and Seahorse Biosciences. Mr. Henrichs is the past-President of the Massachusetts's Service Alliance, a member of the Board of Directors of Britemoon, Inc. (sold to ClickTactics).